Yasuko Fukuya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yasuko Fukuya has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Chie Miyabe
Division of Dermatology, Department of Dermatology Tokyo Women's Medical University Tokyo Japan
3 shared publications Naoko Ishiguro
Department of Dermatology Tokyo Women's Medical University Tokyo Japan
3 shared publicationsRyujin Miyata
Department of Dermatology Tokyo Women's Medical University Tokyo Japan
3 shared publications- Naoko Ishiguro
Department of Dermatology Tokyo Women's Medical University Tokyo Japan
2 shared publications Akari Kondo
Department of Dermatology Tokyo Women's Medical University School of Medicine Tokyo Japan
1 shared publication- Akiko Mochizuki
Department of Dermatology Tokyo Women's Medical University Tokyo Japan
1 shared publication
Latest Publications
- 17 March 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (3) , e70084
Comparative Analysis of the Skin Microbiota of Rosacea, Steroid‐Induced Rosacea and Perioral Dermatitis
Rosacea, steroid‐induced rosacea, also known as corticosteroid‐induced rosacea‐like dermatitis, and perioral dermatitis cause erythema, red papules, and pustules on the face. Tetracycline therapy is often effective for these skin diseases, suggesting that skin bacteria may be involved in these pathogeneses. To explore the etiologic significance of skin bacteria, we examined the microbiota of rosacea, steroid‐induced rosacea, and perioral dermatitis, as well as healthy participants (n = 50), using swab specimens that were obtained by rubbing the skin surface and vellus hair specimens that were collected from the perioral lesions. Skin microbiota was determined with short‐amplicon sequence analysis for 16S rRNA gene (V1–V2 regions). Comparative analysis of the microbiota showed that the bacterial composition in perioral dermatitis cases was clearly different from that of rosacea cases and healthy participants but similar to that of some cases of steroid‐induced rosacea. The uncultured Neisseriales bacterium was prevalent in the skin microbiota of some cases of steroid‐induced rosacea and perioral dermatitis cases. After antibiotic therapy to steroid‐induced rosacea and perioral dermatitis cases, the uncultured Neisseriales bacterium disappeared with improvement of the skin rash. These results indicate that the skin bacteria involving unculturable bacterium in the skin microbiota had a significant impact on steroid‐induced rosacea and perioral dermatitis pathogeneses, and that microbiota‐targeted treatment may be effective for steroid‐induced rosacea and perioral dermatitis.
- 17 March 2025
- Published by Wiley in Experimental Dermatology
- Vol. 34 (3) , e70084
Comparative Analysis of the Skin Microbiota of Rosacea, Steroid‐Induced Rosacea and Perioral Dermatitis
Rosacea, steroid‐induced rosacea, also known as corticosteroid‐induced rosacea‐like dermatitis, and perioral dermatitis cause erythema, red papules, and pustules on the face. Tetracycline therapy is often effective for these skin diseases, suggesting that skin bacteria may be involved in these pathogeneses. To explore the etiologic significance of skin bacteria, we examined the microbiota of rosacea, steroid‐induced rosacea, and perioral dermatitis, as well as healthy participants (n = 50), using swab specimens that were obtained by rubbing the skin surface and vellus hair specimens that were collected from the perioral lesions. Skin microbiota was determined with short‐amplicon sequence analysis for 16S rRNA gene (V1–V2 regions). Comparative analysis of the microbiota showed that the bacterial composition in perioral dermatitis cases was clearly different from that of rosacea cases and healthy participants but similar to that of some cases of steroid‐induced rosacea. The uncultured Neisseriales bacterium was prevalent in the skin microbiota of some cases of steroid‐induced rosacea and perioral dermatitis cases. After antibiotic therapy to steroid‐induced rosacea and perioral dermatitis cases, the uncultured Neisseriales bacterium disappeared with improvement of the skin rash. These results indicate that the skin bacteria involving unculturable bacterium in the skin microbiota had a significant impact on steroid‐induced rosacea and perioral dermatitis pathogeneses, and that microbiota‐targeted treatment may be effective for steroid‐induced rosacea and perioral dermatitis.
- 4 August 2022
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (3) , E165-E167
Lithium carbonate‐induced Stevens‐Johnson syndrome: the first case report
- 4 August 2022
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (3) , E165-E167
Lithium carbonate‐induced Stevens‐Johnson syndrome: the first case report
- 28 October 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (8) , E278-E280
Skin lesions as the initial sign of systemic relapse in a case of Waldenström's macroglobulinemia
- 28 October 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (8) , E278-E280
Skin lesions as the initial sign of systemic relapse in a case of Waldenström's macroglobulinemia
- 24 August 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (11) , E556-E557
Hypergammaglobulinemic purpura: Does hypergammaglobulinemia cause purpura?
- 24 August 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (11) , E556-E557
Hypergammaglobulinemic purpura: Does hypergammaglobulinemia cause purpura?
- 2 February 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (4) , E157-E158
A case of non‐uremic calciphylaxis associated with systemic lupus erythematosus and antiphospholipid syndrome
- 2 February 2021
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (4) , E157-E158
A case of non‐uremic calciphylaxis associated with systemic lupus erythematosus and antiphospholipid syndrome
- 1 September 2009
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1173 (1) , 137-145
Possible Involvement of Chemokine‐induced Platelet Activation in Thrombophilic Diathesis of Antiphospholipid Syndrome
Among the heterogeneous antiphospholipid antibodies, many studies suggest that those directed to β2‐glycoprotein I (β2GPI) are the major pathogenic antibodies in antiphospholipid syndrome (APS). They have been shown to activate the coagulation pathway via several mechanisms, activate platelets via thrombin formation, and suppress fibrinolysis. Additionally, we propose another possible mechanism that involves certain chemokines and results in platelet activation. This hypothesis is based on the observations that anti‐β2GPI antibodies stimulated monocytes to secrete inflammatory cytokines such as IL‐1β and TNF‐α, which in turn stimulated vascular endothelial cells to express chemokines such as CX3CL1 and CCL5. CX3CL1 increased the ability of normal platelets to adhere to collagen at a high shear rate, while CCL5 induced platelet aggregation. Expression of tissue factor, IL‐1β, and TNF‐α by monocytes stimulated with anti‐β2GPI antibodies, as well as CX3CL1 and CCL5 by vascular endothelial cells stimulated with IL‐1β or TNF‐α were all suppressed by the NF‐κB–specific inhibitor DHMEQ. These results suggest that the NF‐κB pathway may be a potential therapeutic target relating to both the coagulation pathway and platelet activity.
- 1 September 2009
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1173 (1) , 137-145
Possible Involvement of Chemokine‐induced Platelet Activation in Thrombophilic Diathesis of Antiphospholipid Syndrome
Among the heterogeneous antiphospholipid antibodies, many studies suggest that those directed to β2‐glycoprotein I (β2GPI) are the major pathogenic antibodies in antiphospholipid syndrome (APS). They have been shown to activate the coagulation pathway via several mechanisms, activate platelets via thrombin formation, and suppress fibrinolysis. Additionally, we propose another possible mechanism that involves certain chemokines and results in platelet activation. This hypothesis is based on the observations that anti‐β2GPI antibodies stimulated monocytes to secrete inflammatory cytokines such as IL‐1β and TNF‐α, which in turn stimulated vascular endothelial cells to express chemokines such as CX3CL1 and CCL5. CX3CL1 increased the ability of normal platelets to adhere to collagen at a high shear rate, while CCL5 induced platelet aggregation. Expression of tissue factor, IL‐1β, and TNF‐α by monocytes stimulated with anti‐β2GPI antibodies, as well as CX3CL1 and CCL5 by vascular endothelial cells stimulated with IL‐1β or TNF‐α were all suppressed by the NF‐κB–specific inhibitor DHMEQ. These results suggest that the NF‐κB pathway may be a potential therapeutic target relating to both the coagulation pathway and platelet activity.